EPO and thanatophoric dysplasia: EFAs derivatives (PGE1, PGE2) antagonize the dopamine function by cyclic adenosine -3’,5’- monophosphate, thereupon, EPO could block the hyperactivity of dopamine causing TD by conversion to DGLA and AA (precursors of PGE1 and PGE2).